Is Apoptosis Key in Alzheimer's Disease?
- 28 August 1998
- news
- Published by American Association for the Advancement of Science (AAAS)
- Vol. 281 (5381) , 1303-1304
- https://doi.org/10.1126/science.281.5381.1303
Abstract
Researchers have found that the brains of Alzheimer9s patients contain dying neurons that display some characteristic signs of cell suicide (apoptosis), such as DNA breaks and activation of enzymes called caspases that carry out the death program. Because the neurons don9t display all the typical apoptosis signs, researchers are divided over whether they really are dying a programmed death. And even if they are, there are questions about whether anti-apoptotic drugs will help Alzheimer9s patients since lack of a good animal model of the disease has prevented tests to see whether the cellular equivalent of suicide intervention will help slow the disease9s progression. But despite the uncertainties, many Alzheimer9s experts think the issue is worth pursuing, because if apoptosis does turn out to play a role in the nerve cell loss of the disease, the finding could lead to badly needed new therapies.This publication has 6 references indexed in Scilit:
- Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1and results in apoptosis and tumor suppressionNature Medicine, 1998
- Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral IschemiaJournal of Neuroscience, 1998
- Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.Journal of Clinical Investigation, 1998
- Alternative Cleavage of Alzheimer-Associated Presenilins During Apoptosis by a Caspase-3 Family ProteaseScience, 1997
- Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damageProceedings of the National Academy of Sciences, 1997
- A potential role for apoptosis in neurodegeneration and Alzheimer's diseaseMolecular Neurobiology, 1995